[New strategies and perspectives in thrombolytic therapy].
Bode
C
C
Medizinische Klinik III (Kardiologie, Pulmologie und Angiologie), Universität Heidelberg.
Kübler
W
W
D001780:Blood Coagulation Tests; D004305:Dose-Response Relationship, Drug; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000379:methods*; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator
Neue Strategien und Perspektiven der Thrombolysetherapie.